Wayne P. Rothbaum, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 5,000,000 shares at $9.15 ($45.8M) on 2024-02-20, disclosed to the SEC on 2024-02-20.
Open-market purchase of $45.8M IOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| IOVA | BUY | 2022-06-02 | $6.6M | — | Filing → |
| IOVA | BUY | 2018-12-07 | $22.0M | — | Filing → |